Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-004373

Options or other derivatives

  • Chief Business & Strgy Officer acquired 1,918,392 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer 2023-01-17 Grant or award · Option to purchase Ordinary Shares +1,407,072 1,407,072 D
TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer 2023-01-17 Grant or award · Option to purchase Ordinary Shares +314,256 314,256 D
TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer 2023-01-17 Grant or award · Option to purchase Ordinary Shares +197,064 197,064 D
Loading xslF345X03/tm231655-13_4seq1.xml…